For research use only. Not for therapeutic Use.
Ecallantide (DX-88) TFA is a specific recombinant plasma kallikrein inhibitor. Ecallantide inhibits the production of bradykinin. Ecallantide may be used to prevent acute attacks of angioedema[1].
Catalog Number | I040339 |
Molecular Formula | C305H442N88O91S8.xC2HF3O2 |
Purity | ≥95% |
Reference | [1]. Martello JL, et al. Ecallantide for treatment of acute attacks of hereditary angioedema. Am J Health Syst Pharm. 2012 Apr 15;69(8):651-7. [Content Brief] |